FDA announces additional risks of Essure birth control device

Last updated on: June 28, 2015 at 10:39 pm by CNA Daily News

FDA announces additional risks of Essure birth control device 2015-06-28T22:39:00+00:00 CNA Daily News

LOGO Patheos Explore the world's faith through different perspectives on religion and spirituality! Patheos has the views of the prevalent religions and spiritualities of the world.

Denver, Colo., Jun 28, 2015 / 04:39 pm (CNA/EWTN News).- After receiving thousands of complaints about the adverse effects of the birth control implant Essure, the FDA announced late Wednesday that it has updated the list of risks and complications associated with the device, and that a public hearing would be held Sept. 24 to evaluate the product.

Essure is a permanent type of birth control in the form of tiny metal coils inserted into women’s Fallopian tubes. When the coils are implanted they are supposed to stay in the Fallopian tubes, where they create a chronic infection that will cause scar tissue to form around the coils, effectively closing the tubes and rendering the woman sterile.

Until this week, possible side effects of Essure listed on the product’s website included: “mild to moderate pain and/or cramping, vaginal bleeding, and pelvic or back discomfort for a few days. Some women experienced nausea and/or vomiting or fainting. In rare instances, an Essure insert may be expelled from the body.”

Angela Desa-Lynch, an administrator for the Facebook group “Essure Problems”, which protests the device, told CNA in February that the thousands of women in the group had experienced these problems to the extreme.

“Whatever they’ve put on the label, multiply it by 200,” she told CNA in February.

At least five deaths of women, and five deaths of fetuses in women who’ve been implanted with Essure, have been reported. Other side effects many of the “Essure Problems” women have experienced include perforated organs, coils lodged in colons, fetal disfigurement due to nickel poisoning, chronic pain, exhaustion, bouts of depression, and suicidal thoughts.

The group, which grew from about 14,000 to over 18,000 just since February, seeks to inform and save every woman they can from getting Essure implants. In a statement on their website, the group said they feel encouraged by the FDA’s announcement.

“We feel like the FDA has really been listening to us, to our group, and is taking some steps in the right direction to address the serious complications and problems with this device,” it reads.

“Having a large government agency paying attention to a group of women harmed by a medical device, and making arrangements to review information and allowing our voices to be heard, is huge,” the group said.

“We plan to bring with us as many of the original clinical trial participants as we can get there, along with our supporting physicians. We need every women harmed by Essure to get to this meeting. We need every media outlet there. All are welcome. Let’s fill the room and pour into the hallways. Let your faces be seen, and let your pain serve a purpose. Not one more woman harmed by Essure.”

The device was first manufactured by the group Conceptus and was pre-approved by the FDA before hitting the markets in 2002. In June 2014, Conceptus was bought by Bayer, which has continued to manufacture and distribute Essure.

In a statement released Thursday, Bayer said: “Patient safety is Bayer’s top priority. Given there has been a great deal of interest in the safety of Essure among some patients, we welcome this open dialogue with healthcare providers, patients, researchers, representatives from professional societies, and other members of the public to review and discuss available data regarding the benefits and risks associated with Essure.”

“Bayer is strongly committed to women having access to safe and effective birth control options. The only FDA-approved non-surgical option for women who have completed their families and want permanent contraception, Essure is supported by more than a decade of science and real world clinical experience.”

The announcement by the FDA and the promise of the September meeting is a step forward for the Essure Problems group, which has enlisted the help of environmental lawyer Erin Brockovich (yes, that one) in a few pending lawsuits to get Essure taken off the market.

The end of the statement from the group, which refers to their fellow members as “E-sisters”, reads: “Bound by pain, we will never stop until Essure is off the market.”

Previous Post

June 28, 2015

Pope Francis' answer to 'What is faith?'

Next Post

June 29, 2015 Supreme Court upholds use of controversial lethal injection drug

Browse Our Archives

Select a Category Americas Asia - Pacific Europe Middle East - Africa Uncategorized US Vatican

Select a Month November 2017 October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 June 2016 May 2016 April 2016 March 2016 February 2016 January 2016 December 2015 November 2015 October 2015 September 2015 August 2015 July 2015 June 2015 May 2015 April 2015 March 2015 February 2015 January 2015 December 2014 November 2014 October 2014 September 2014 August 2014 July 2014 June 2014 May 2014 April 2014 March 2014 February 2014 January 2014 December 2013 November 2013 October 2013 September 2013 August 2013 July 2013 June 2013 May 2013 April 2013 March 2013 February 2013 January 2013 December 2012 November 2012 October 2012 September 2012 August 2012 July 2012 June 2012 May 2012

TAKE THE

Religious Wisdom Quiz

True or False: 1 John teaches that if we say we have no sin, we deceive ourselves.

Select your answer to see how you score.

TRUE FALSE